Development asset linked to ARTELO BIOSCIENCES in public FDA and regional records.
pharma · Cancer Anorexia · ARTL
ARTELO BIOSCIENCES
ARTELO BIOSCIENCES, INC.
ARTELO BIOSCIENCES drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
La Jolla, USA HQ
2017 Founded
16 Employees
Public company Type
ARTL · NYSE Ticker
Company details
- Status
- Public
- HQ
- La Jolla, USA
- Founded
- 2017
- Employees
- 16
- Programs
- 1
- Drugs
- 1
- Patents
- 2
ARTELO BIOSCIENCES pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
ARTELO BIOSCIENCES drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.